Your browser doesn't support javascript.
loading
Effect of simvastatin on monocyte CX3CR1 expression in patients with acute coronary syndrome / 南方医科大学学报
Journal of Southern Medical University ; (12): 475-477, 2008.
Artigo em Chinês | WPRIM | ID: wpr-293348
ABSTRACT
<p><b>OBJECTIVE</b>To observe the effect of simvastatin on expression of CX3CR1 in the monocytes in patients with acute coronary syndrome and investigate the non-lipid mechanisms of statins against atherosclerosis.</p><p><b>METHODS</b>The expression of CX3CR1 in the monocytes was measured by quantitative real-time RT-PCR in 63 patients with acute coronary syndrome confirmed by coronary arteriography after treatment with simvastatin at 10(-7) approximately 10(-5) mol/L for 4, 8 and 12 h, respectively.</p><p><b>RESULTS</b>CX3CR1 expression in the monocytes treated with different concentrations of simvastatin was significantly lower than that in the control cells (P<0.05), and the expression in the cells treated with the agent for different time lengths was also significantly lower than that in the control cells (P<0.01).</p><p><b>CONCLUSION</b>Simvastatin can reduce CX3CR1 expression in the monocytes of the patients with acute coronary syndrome in a concentration- and time-dependent manner, so as to reduce the inflammation and stabilize the vascular plaques.</p>
Assuntos
Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Sangue / Monócitos / Expressão Gênica / Sinvastatina / Receptores de Quimiocinas / Reação em Cadeia da Polimerase Via Transcriptase Reversa / Usos Terapêuticos / Tratamento Farmacológico / Síndrome Coronariana Aguda / Receptor 1 de Quimiocina CX3C Limite: Feminino / Humanos / Masculino Idioma: Chinês Revista: Journal of Southern Medical University Ano de publicação: 2008 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Sangue / Monócitos / Expressão Gênica / Sinvastatina / Receptores de Quimiocinas / Reação em Cadeia da Polimerase Via Transcriptase Reversa / Usos Terapêuticos / Tratamento Farmacológico / Síndrome Coronariana Aguda / Receptor 1 de Quimiocina CX3C Limite: Feminino / Humanos / Masculino Idioma: Chinês Revista: Journal of Southern Medical University Ano de publicação: 2008 Tipo de documento: Artigo